Cargando…
HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer
BACKGROUND: Most cancer cells have fundamentally different metabolic characteristics, particularly much higher glycolysis rates than normal tissues, which support the increased demand for biosynthesis and promote tumor progression. We found that transforming growth factor (TGF)-β plays a dual functi...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690885/ https://www.ncbi.nlm.nih.gov/pubmed/34930376 http://dx.doi.org/10.1186/s13046-021-02188-y |
_version_ | 1784618696517353472 |
---|---|
author | Huang, Yiwei Chen, Zhencong Lu, Tao Bi, Guoshu Li, Ming Liang, Jiaqi Hu, Zhengyang Zheng, Yuansheng Yin, Jiacheng Xi, Junjie Lin, Zongwu Zhan, Cheng Jiang, Wei Wang, Qun Tan, Lijie |
author_facet | Huang, Yiwei Chen, Zhencong Lu, Tao Bi, Guoshu Li, Ming Liang, Jiaqi Hu, Zhengyang Zheng, Yuansheng Yin, Jiacheng Xi, Junjie Lin, Zongwu Zhan, Cheng Jiang, Wei Wang, Qun Tan, Lijie |
author_sort | Huang, Yiwei |
collection | PubMed |
description | BACKGROUND: Most cancer cells have fundamentally different metabolic characteristics, particularly much higher glycolysis rates than normal tissues, which support the increased demand for biosynthesis and promote tumor progression. We found that transforming growth factor (TGF)-β plays a dual function in regulating glycolysis and cell proliferation in non-small cell lung cancer. METHODS: We used the PET/MRI imaging system to observe the glucose metabolism of subcutaneous tumors in nude mice. Energy metabolism of non-small cell lung cancer cell lines detected by the Seahorse XFe96 cell outflow analyzer. Co-immunoprecipitation assays were used to detect the binding of Smads and HIF-1α. Western blotting and qRT-PCR were used to detect the regulatory effects of TGF-β and HIF-1α on c-MYC, PKM1/2, and cell cycle-related genes. RESULTS: We discovered that TGF-β could inhibit glycolysis under normoxia while significantly promoting tumor cells’ glycolysis under hypoxia in vitro and in vivo. The binding of hypoxia-inducible factor (HIF)-1α to the MH2 domain of phosphorylated Smad3 switched TGF-β function to glycolysis by changing Smad partners under hypoxia. The Smad-p107-E2F4/5 complex that initially inhibited c-Myc expression was transformed into a Smad-HIF-1α complex that promoted the expression of c-Myc. The increased expression of c-Myc promoted alternative splicing of PKM to PKM2, resulting in the metabolic reprogramming of tumor cells. In addition, the TGF-β/Smad signal lost its effect on cell cycle regulatory protein p15/p21. Furthermore, high expression of c-Myc inhibited p15/p21 and promoted the proliferation of tumor cells under hypoxia. CONCLUSIONS: Our results indicated that HIF-1α functions as a critical factor in the dual role of TGF-β in tumor cells, and may be used as a biomarker or therapeutic target for TGF-β mediated cancer progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02188-y. |
format | Online Article Text |
id | pubmed-8690885 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-86908852021-12-21 HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer Huang, Yiwei Chen, Zhencong Lu, Tao Bi, Guoshu Li, Ming Liang, Jiaqi Hu, Zhengyang Zheng, Yuansheng Yin, Jiacheng Xi, Junjie Lin, Zongwu Zhan, Cheng Jiang, Wei Wang, Qun Tan, Lijie J Exp Clin Cancer Res Research BACKGROUND: Most cancer cells have fundamentally different metabolic characteristics, particularly much higher glycolysis rates than normal tissues, which support the increased demand for biosynthesis and promote tumor progression. We found that transforming growth factor (TGF)-β plays a dual function in regulating glycolysis and cell proliferation in non-small cell lung cancer. METHODS: We used the PET/MRI imaging system to observe the glucose metabolism of subcutaneous tumors in nude mice. Energy metabolism of non-small cell lung cancer cell lines detected by the Seahorse XFe96 cell outflow analyzer. Co-immunoprecipitation assays were used to detect the binding of Smads and HIF-1α. Western blotting and qRT-PCR were used to detect the regulatory effects of TGF-β and HIF-1α on c-MYC, PKM1/2, and cell cycle-related genes. RESULTS: We discovered that TGF-β could inhibit glycolysis under normoxia while significantly promoting tumor cells’ glycolysis under hypoxia in vitro and in vivo. The binding of hypoxia-inducible factor (HIF)-1α to the MH2 domain of phosphorylated Smad3 switched TGF-β function to glycolysis by changing Smad partners under hypoxia. The Smad-p107-E2F4/5 complex that initially inhibited c-Myc expression was transformed into a Smad-HIF-1α complex that promoted the expression of c-Myc. The increased expression of c-Myc promoted alternative splicing of PKM to PKM2, resulting in the metabolic reprogramming of tumor cells. In addition, the TGF-β/Smad signal lost its effect on cell cycle regulatory protein p15/p21. Furthermore, high expression of c-Myc inhibited p15/p21 and promoted the proliferation of tumor cells under hypoxia. CONCLUSIONS: Our results indicated that HIF-1α functions as a critical factor in the dual role of TGF-β in tumor cells, and may be used as a biomarker or therapeutic target for TGF-β mediated cancer progression. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13046-021-02188-y. BioMed Central 2021-12-20 /pmc/articles/PMC8690885/ /pubmed/34930376 http://dx.doi.org/10.1186/s13046-021-02188-y Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Huang, Yiwei Chen, Zhencong Lu, Tao Bi, Guoshu Li, Ming Liang, Jiaqi Hu, Zhengyang Zheng, Yuansheng Yin, Jiacheng Xi, Junjie Lin, Zongwu Zhan, Cheng Jiang, Wei Wang, Qun Tan, Lijie HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer |
title | HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer |
title_full | HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer |
title_fullStr | HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer |
title_full_unstemmed | HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer |
title_short | HIF-1α switches the functionality of TGF-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer |
title_sort | hif-1α switches the functionality of tgf-β signaling via changing the partners of smads to drive glucose metabolic reprogramming in non-small cell lung cancer |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690885/ https://www.ncbi.nlm.nih.gov/pubmed/34930376 http://dx.doi.org/10.1186/s13046-021-02188-y |
work_keys_str_mv | AT huangyiwei hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT chenzhencong hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT lutao hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT biguoshu hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT liming hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT liangjiaqi hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT huzhengyang hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT zhengyuansheng hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT yinjiacheng hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT xijunjie hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT linzongwu hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT zhancheng hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT jiangwei hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT wangqun hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer AT tanlijie hif1aswitchesthefunctionalityoftgfbsignalingviachangingthepartnersofsmadstodriveglucosemetabolicreprogramminginnonsmallcelllungcancer |